Dilevalol (Compound)

Compound:

DCSTRUCT ID 00894

Synonyms:Dilevalol, 75659-07-3, (R,R)-Labetalol, 2-Hydroxy-5-((R)-1-hydroxy-2-(((R)-4-phenylbutan-2-yl)amino)ethyl)benzamide, 72487-32-2, 2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-4-phenylbutan-2-yl]amino]ethyl]benzamide, P6629XE33T, Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, (R-(R*,R*))-, Dilevalon, Levadil

Id:134044

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Dilevalol's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Dilevalol.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Dilevalol.

Results found

Linked to

	Label	Description
	BRD-K04389336-001-01-1 Substance (Entity type)	A Substance
	DCSTRUCT ID 00894 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00894; PubChem_CID:134044, FILE=drugcentral_drug_00894.json)

BRD-K04389336-001-01-1

Substance (Entity type)

A Substance

DCSTRUCT ID 00894

Collection (Entity type)

DrugPage Collection: (DrugCentralID:00894; PubChem_CID:134044, FILE=drugcentral_drug_00894.json)

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.